Exenatide is a 39-amino acid peptide and it is a synthetic version of Exendin-4. Exenatide is a medication used to treat diabetes mellitus type2. AULBIO has developed a monthly dosage form of Exenatide that reduces the frequency of treatment to improve the patient's compliance. As a result of verifying the efficacy in ZDF, superior results were obtained compared to the formulation administered daily. Based on the results, a clinical trial is currently being prepared.